This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Influenza mRNA Vaccines
April 27, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

Industry Interviews

Welcome to our new Industry Spotlights podcast where you can expect to hear the latest from our industry and academic experts presenting at Influenza mRNA Vaccines. We'll be highlighting the ground-breaking work in this therapeutic area and giving you a taster of what you can expect to hear on the day.

volume_up

Industry Spotlight

Hear from Jane True, Vice President for mRNA commercial Strategy and Innovation and Global Pandemic Security Lead at Pfizer We’ll be discussing mRNA platform approaches developed in response to COVID and how these are being used to develop the next generation of vaccines.

volume_up

Industry Spotlight

Hear from John S Tregoning, Reader in Respiratory Infections at Imperial College London on the future of mRNA-based vaccines, adaptive immunity, and its impact on public health.